TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
Brief Summary: This trial is conducted in Africa and Asia. The aim of the trial is to investigate the efficacy and safety of liraglutide versus sulphonylurea (SU) both in combination with metformin during Ramadan in subjects with type 2 diabetes (T2DM).


Options:
A: Arm Label: Canagliflozin + Metformin; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin | Arm Label: Repaglinide + Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Repaglinide | Arm Label: Pioglitazone + Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pioglitazone | Arm Label: Gliclazide + Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Gliclazide | Arm Label: Glimepiride + Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Glimepiride | Intervention Type: DRUG; Name: Canagliflozin; Assigned to Arm(s): Canagliflozin + Metformin | Intervention Type: DRUG; Name: Repaglinide; Assigned to Arm(s): Repaglinide + Metformin | Intervention Type: DRUG; Name: Pioglitazone; Assigned to Arm(s): Pioglitazone + Metformin | Intervention Type: DRUG; Name: Gliclazide; Assigned to Arm(s): Gliclazide + Metformin | Intervention Type: DRUG; Name: Glimepiride; Assigned to Arm(s): Glimepiride + Metformin
B: Arm Label: Intervention; Type: OTHER; Interventions: Other: FAST | Arm Label: Control; Type: OTHER; Interventions: Other: Standard of care | Intervention Type: OTHER; Name: FAST; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Standard of care; Assigned to Arm(s): Control
C: Arm Label: Liraglutide+Metformin; Type: EXPERIMENTAL; Interventions: Drug: liraglutide, Drug: metformin | Arm Label: Sulphonylurea and Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin, Drug: sulphonylurea | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Liraglutide+Metformin | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): Liraglutide+Metformin, Sulphonylurea and Metformin | Intervention Type: DRUG; Name: sulphonylurea; Assigned to Arm(s): Sulphonylurea and Metformin
D: Arm Label: Sitagliptin; Type: EXPERIMENTAL; Interventions: Drug: Sitagliptin, Drug: Metformin | Arm Label: Sulfonylurea Therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sulfonylurea, Drug: Metformin | Intervention Type: DRUG; Name: Sitagliptin; Assigned to Arm(s): Sitagliptin | Intervention Type: DRUG; Name: Sulfonylurea; Assigned to Arm(s): Sulfonylurea Therapy | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Sitagliptin, Sulfonylurea Therapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Low Dose Aspirin and Low-molecular-weight Heparin in the Treatment of Pregnant Libyan Women With Recurrent Miscarriage
Brief Summary: Efficacy of low dose aspirin (LDA) versus LDA plus low-molecular-weight-heparin (LMWH) in patients with a history of recurrent miscarriages.


Options:
A: Arm Label: Aspirin; Type: EXPERIMENTAL; Interventions: Drug: Aspirin | Arm Label: Aspirin + heparin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin, Drug: Heparin | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): Aspirin, Aspirin + heparin | Intervention Type: DRUG; Name: Heparin; Assigned to Arm(s): Aspirin + heparin
B: Arm Label: enoxaparin 40 mg plus low dose aspirin; Type: EXPERIMENTAL; Interventions: Drug: enoxaparin 40mg plus low dose aspirin | Arm Label: Heparin calcium 5,000 U twice daily plus low dose aspirin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Heparin calcium5,000 U twice daily plus low dose aspirin | Intervention Type: DRUG; Name: enoxaparin 40mg plus low dose aspirin; Assigned to Arm(s): enoxaparin 40 mg plus low dose aspirin | Intervention Type: DRUG; Name: Heparin calcium5,000 U twice daily plus low dose aspirin; Assigned to Arm(s): Heparin calcium 5,000 U twice daily plus low dose aspirin
C: Arm Label: Low molecular weight heparin; Type: N/A; Interventions: Drug: low molecular weight heparin (enoxeparine) | Intervention Type: DRUG; Name: low molecular weight heparin (enoxeparine); Assigned to Arm(s): Low molecular weight heparin
D: Arm Label: Multivitamin supplement; Type: OTHER; Interventions: Dietary Supplement: Multivitamin supplement | Arm Label: Multivitamin supplement + dalteparin sodium; Type: EXPERIMENTAL; Interventions: Drug: Fragmin P Forte (dalteparin sodium) | Intervention Type: DRUG; Name: Fragmin P Forte (dalteparin sodium); Assigned to Arm(s): Multivitamin supplement + dalteparin sodium | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamin supplement; Assigned to Arm(s): Multivitamin supplement

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Lifestyle Intervention in Pregnancy - Follow-up on the Offspring in Early Childhood.
Brief Summary: Children born to obese women are at risk of increased adiposity and later adverse metabolic outcomes. We have conducted a follow-up study on an existing clinical trial, called the LiP study (Lifestyle in Pregnancy), registration number NCT00530439,in which 360 obese pregnant women were randomized to either lifestyle intervention or routine obstetric care. This present study follows the children until 3 years of age. We have the hypothesis, that the intervention during pregnancy results in a lower degree of adiposity and metabolic risk factors in the offspring. Clinical examination is taking place at age 2.5-3 years including anthropometric measurements, Dual energy x-ray (DXA) scans and blood samples measuring metabolic markers.


Options:
A: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention
B: Arm Label: Normative intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Normative Intervention | Arm Label: Routine care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Normative Intervention; Assigned to Arm(s): Normative intervention
C: Arm Label: Usual Care; Type: OTHER; Interventions: Other: Usual Care | Arm Label: Weight Management Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Weight Management | Intervention Type: BEHAVIORAL; Name: Weight Management; Assigned to Arm(s): Weight Management Counseling | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Lifestyle Intervention in Pregnancy - Follow-up on the Offspring in Early Childhood.
Brief Summary: Children born to obese women are at risk of increased adiposity and later adverse metabolic outcomes. We have conducted a follow-up study on an existing clinical trial, called the LiP study (Lifestyle in Pregnancy), registration number NCT00530439,in which 360 obese pregnant women were randomized to either lifestyle intervention or routine obstetric care. This present study follows the children until 3 years of age. We have the hypothesis, that the intervention during pregnancy results in a lower degree of adiposity and metabolic risk factors in the offspring. Clinical examination is taking place at age 2.5-3 years including anthropometric measurements, Dual energy x-ray (DXA) scans and blood samples measuring metabolic markers.


Options:
A: Arm Label: Children of obese women from a RCT; Type: N/A; Interventions: Behavioral: Lifestyle intervention during pregnancy | Arm Label: Children of obese mothers from a RCT, controls; Type: N/A; Interventions: N/A | Arm Label: Children born to normal weight women; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention during pregnancy; Assigned to Arm(s): Children of obese women from a RCT
B: Arm Label: Lifestyle, follow-up, early care, standard care high/low risk; Type: OTHER; Interventions: Behavioral: Lifestyle: diet and exercise | Arm Label: Close follow-up; Type: OTHER; Interventions: Behavioral: Close follow-up: reporting diaries of food and exercise | Intervention Type: BEHAVIORAL; Name: Lifestyle: diet and exercise; Assigned to Arm(s): Lifestyle, follow-up, early care, standard care high/low risk | Intervention Type: BEHAVIORAL; Name: Close follow-up: reporting diaries of food and exercise; Assigned to Arm(s): Close follow-up
C: Arm Label: Intensive Counseling Group; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary and lifestyle counseling | Arm Label: Routine care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary and lifestyle counseling; Assigned to Arm(s): Intensive Counseling Group
D: Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Lifestyle intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Lifestyle Intervention During Pregnancy in Obese Women on Offspring Adiposity and Metabolic Risk Factors- Comparison With Offspring of Normal Weight Women Not Participating in a Lifestyle Intervention Programme.
Brief Summary: Children born to obese women are at risk of increased adiposity and later adverse metabolic outcomes. We have conducted a follow-up study on an existing clinical trial, called the LiP study (Lifestyle in Pregnancy), registration number NCT00530439,in which 360 obese pregnant women were randomized to either lifestyle intervention or routine obstetric care. This present study follows the children until 3 years of age. We have the hypothesis, that the intervention during pregnancy results in a lower degree of adiposity and metabolic risk factors in the offspring. Clinical examination is taking place at age 2.5-3 years including anthropometric measurements, Dual energy x-ray (DXA) scans and blood samples measuring metabolic markers.In addition, we have included an extra control group of children born to normal weight women, who were not part of a lifestyle intervention program during pregnancy. We have the hypothesis that the children of the normal weight women have a better metabolic profile than the children born to the obese women.


Options:
A: Arm Label: Children of obese women from a RCT; Type: N/A; Interventions: Behavioral: Lifestyle intervention during pregnancy | Arm Label: Children of obese mothers from a RCT, controls; Type: N/A; Interventions: N/A | Arm Label: Children born to normal weight women; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention during pregnancy; Assigned to Arm(s): Children of obese women from a RCT
B: Arm Label: Nutritional counseling & self blood glucose monitoring; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: nutritional counseling, Behavioral: self blood glucose monitoring | Arm Label: No treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: nutritional counseling; Assigned to Arm(s): Nutritional counseling & self blood glucose monitoring | Intervention Type: BEHAVIORAL; Name: self blood glucose monitoring; Assigned to Arm(s): Nutritional counseling & self blood glucose monitoring
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: MOMs Healthy Lifestyle Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy MOMs Healthy Lifestyle Intervention | Intervention Type: BEHAVIORAL; Name: Healthy MOMs Healthy Lifestyle Intervention; Assigned to Arm(s): MOMs Healthy Lifestyle Intervention
D: Arm Label: Usual Care; Type: OTHER; Interventions: Other: Usual Care | Arm Label: Weight Management Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Weight Management | Intervention Type: BEHAVIORAL; Name: Weight Management; Assigned to Arm(s): Weight Management Counseling | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Lifestyle Intervention During Pregnancy in Obese Women on Offspring Adiposity and Metabolic Risk Factors- Comparison With Offspring of Normal Weight Women Not Participating in a Lifestyle Intervention Programme.
Brief Summary: Children born to obese women are at risk of increased adiposity and later adverse metabolic outcomes. We have conducted a follow-up study on an existing clinical trial, called the LiP study (Lifestyle in Pregnancy), registration number NCT00530439,in which 360 obese pregnant women were randomized to either lifestyle intervention or routine obstetric care. This present study follows the children until 3 years of age. We have the hypothesis, that the intervention during pregnancy results in a lower degree of adiposity and metabolic risk factors in the offspring. Clinical examination is taking place at age 2.5-3 years including anthropometric measurements, Dual energy x-ray (DXA) scans and blood samples measuring metabolic markers.In addition, we have included an extra control group of children born to normal weight women, who were not part of a lifestyle intervention program during pregnancy. We have the hypothesis that the children of the normal weight women have a better metabolic profile than the children born to the obese women.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: MOMs Healthy Lifestyle Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy MOMs Healthy Lifestyle Intervention | Intervention Type: BEHAVIORAL; Name: Healthy MOMs Healthy Lifestyle Intervention; Assigned to Arm(s): MOMs Healthy Lifestyle Intervention
B: Arm Label: Children of obese women from a RCT; Type: N/A; Interventions: Behavioral: Lifestyle intervention during pregnancy | Arm Label: Children of obese mothers from a RCT, controls; Type: N/A; Interventions: N/A | Arm Label: Children born to normal weight women; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention during pregnancy; Assigned to Arm(s): Children of obese women from a RCT
C: Arm Label: Marinol; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Marinol D-40 | Arm Label: Nutrition counseling; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Marinol D-40; Assigned to Arm(s): Marinol
D: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise group | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise group; Assigned to Arm(s): Exercise group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Point-of-care (POC) C-reactive Protein Testing to Reduce Inappropriate Use of Antibiotics for Acute Respiratory Infections (ARIs) in the Primary Health Care Setting of Hanoi - a Randomized Controlled Trial
Brief Summary: Many studies have showed that rapid point-of-care (POC) c-reactive protein (CRP) test can reduce inappropriate use of antibiotic at primary health care level. In Vietnam, prevalence of antibiotic abuse for community acute respiratory infection has been reported. This study will test the hypothesis that CRP POC testing for patients with non-severe acute respiratory illness at primary healthcare stations reduces inappropriate antibiotic use safely.

The study will be conducted at ten district health care facilities in Hanoi, Viet Nam. Investigators intend to enroll 2,000 participants aged 6-65 years with non-severe acute respiratory infection. Patients will be randomly allocated to the control or the intervention arm. Participants in the control group will be treated according to routine care. Participants in the intervention arm will have a CRP test, the results of which will be available to the health care practitioner to contribute to their diagnosis and treatment decisions.

All patients will be followed-up via telephone call after 14 days. The study will compare the proportion of patients in each arm receiving any antibiotics within 2 weeks of study enrollment.


Options:
A: Arm Label: CRP intervention; Type: EXPERIMENTAL; Interventions: Procedure: Patients will be tested by rapid POC CRP test | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Patients will be tested by rapid POC CRP test; Assigned to Arm(s): CRP intervention
B: Arm Label: CRP-Control; Type: OTHER; Interventions: Other: No CRP will be measured onsite | Arm Label: CRP-A; Type: OTHER; Interventions: Other: CRP cut-off of 20mg/L. | Arm Label: CRP-B; Type: OTHER; Interventions: Other: CRP cut-off of 40mg/L. | Intervention Type: OTHER; Name: No CRP will be measured onsite; Assigned to Arm(s): CRP-Control | Intervention Type: OTHER; Name: CRP cut-off of 20mg/L.; Assigned to Arm(s): CRP-A | Intervention Type: OTHER; Name: CRP cut-off of 40mg/L.; Assigned to Arm(s): CRP-B
C: Arm Label: C-reactive protein test; Type: EXPERIMENTAL; Interventions: Device: C-reactive protein test | Intervention Type: DEVICE; Name: C-reactive protein test; Assigned to Arm(s): C-reactive protein test
D: Intervention Type: BEHAVIORAL; Name: Educational intervention; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Educational intervention program; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Center for Stroke Disparities Solution (CSDS) Project II: Community Transitions Intervention (CTI)
Brief Summary: The Stroke CTI study is a 3 arm randomized, controlled trial designed to assess the effectiveness of a nurse practitioner (NP) only and a NP and health coach (HC) community transitions intervention (CTI) in reducing secondary stroke risk by helping patients lower their systolic blood pressure.


Options:
A: Arm Label: Usual Home Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Nurse Practitioner + Health Coach; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse Practitioner Only, Behavioral: Nurse Practitioner + Health Coach | Arm Label: Nurse Practitioner Only; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse Practitioner Only | Intervention Type: BEHAVIORAL; Name: Nurse Practitioner Only; Assigned to Arm(s): Nurse Practitioner + Health Coach, Nurse Practitioner Only | Intervention Type: BEHAVIORAL; Name: Nurse Practitioner + Health Coach; Assigned to Arm(s): Nurse Practitioner + Health Coach
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention - a validated home BP monitor and support from the specialist nurse | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control - usual care (BP monitoring by their practice) | Intervention Type: BEHAVIORAL; Name: Intervention - a validated home BP monitor and support from the specialist nurse; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Control - usual care (BP monitoring by their practice); Assigned to Arm(s): Control
C: Arm Label: Regular care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Support program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Patient centered structured support program | Intervention Type: BEHAVIORAL; Name: Patient centered structured support program; Assigned to Arm(s): Support program
D: Arm Label: Antiplatelet; Type: ACTIVE_COMPARATOR; Interventions: Drug: aspirin, Drug: clopidogrel, Other: placebo | Arm Label: Blood pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Target of Blood Pressure | Intervention Type: DRUG; Name: aspirin; Assigned to Arm(s): Antiplatelet | Intervention Type: DRUG; Name: clopidogrel; Assigned to Arm(s): Antiplatelet | Intervention Type: OTHER; Name: Target of Blood Pressure; Assigned to Arm(s): Blood pressure | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Antiplatelet

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Intensity Interval Training or Strength Training in Women With Polycystic Ovary Syndrome. A Randomized Controlled Trial
Brief Summary: The aim is to investigate whether strength training or high intensity interval training is effective in improving insulin sensitivity, cardiovascular outcomes, body composition and reproductive outcomes in women with Polycystic Ovary Syndrome (PCOS).

Few studies have examined the effect of strength training alone on insulin sensitivity, reproductive outcomes and body composition in women with PCOS. Most previous studies on aerobic exercise in PCOS have applied moderate exercise intensity.


Options:
A: Intervention Type: DIETARY_SUPPLEMENT; Name: Low carbohydrate; Assigned to Arm(s): N/A
B: Arm Label: Reduced Glycemic Load Diet; Type: OTHER; Interventions: Dietary Supplement: Reduced Glycemic Load Diet | Arm Label: Standard Diet; Type: OTHER; Interventions: Dietary Supplement: Standard Diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Reduced Glycemic Load Diet; Assigned to Arm(s): Reduced Glycemic Load Diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard Diet; Assigned to Arm(s): Standard Diet
C: Arm Label: strength training; Type: EXPERIMENTAL; Interventions: Behavioral: strength training | Arm Label: interval training; Type: EXPERIMENTAL; Interventions: Behavioral: interval training | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: strength training; Assigned to Arm(s): strength training | Intervention Type: BEHAVIORAL; Name: interval training; Assigned to Arm(s): interval training
D: Arm Label: Crispbread; Type: EXPERIMENTAL; Interventions: Behavioral: Crispbread | Arm Label: Liquid meal replacement; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Crispbread | Intervention Type: BEHAVIORAL; Name: Crispbread; Assigned to Arm(s): Crispbread, Liquid meal replacement

Answer: C